Skip to main content
Clinical Trials/DRKS00032390
DRKS00032390
Recruiting
Not Applicable

Abscopal effects in metastasized cancer patients treated with radiotherapy and immune checkpoint inhibition - ARTIC

niversitätsklinikum Köln0 sites62 target enrollmentJuly 31, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Abscopal effects under radio-immunotherapy of all tumour entities treated with it
Sponsor
niversitätsklinikum Köln
Enrollment
62
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 31, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum Köln

Eligibility Criteria

Inclusion Criteria

  • Patients with documented evidence of metastatic solid tumor of any entity and simultaneous RT\-ICI between 06/2015 (start ICI) and 06/2021 (end RT) at participating centers.
  • \- At least one lesion outside the irradiation field: non\-irradiated lesion (outside the 10% isodose, NIL)
  • \- Radiological images of the NILs prior to initiation of RT (at least two) and after the end of RT (at least one) to exclude an effect induced by ICI only

Exclusion Criteria

  • \- Start of another systemic therapy during the time period being analyzed
  • \- Inadequate imaging to assess abscopal effect or exclude response induced by ICI only

Outcomes

Primary Outcomes

Not specified

Similar Trials